A recent study from Northwestern Medicine challenges the conventional understanding of what triggers Parkinson’s disease. While it’s commonly believed that the degeneration of dopaminergic neurons… Read More »New study challenges common belief about what triggers Parkinson’s disease
Researchers in Japan, specifically from Tokyo Medical and Dental University (TMDU), have made significant strides in understanding and potentially treating Parkinson’s disease. This neurodegenerative disorder,… Read More »Mutation in CHCHD2 gene linked to Parkinson’s disease
A groundbreaking discovery has emerged from a collaborative research effort between the University of Lausanne (UNIL) and the Wyss Center. Scientists have unveiled a novel… Read More »New type of brain cell hybridizes neurons and glial cells
A recent study featured in the journal Gut suggests that certain gastrointestinal issues may serve as early warning signs for Parkinson’s disease, a neurological condition.… Read More »Gut problems may be early warning signs of Parkinson’s disease
Researchers from UCL and Moorfields Eye Hospital has identified markers indicating the presence of Parkinson’s disease in patients about seven years before clinical symptoms appear.… Read More »Eye scans can detect Parkinson’s disease 7 years before symptoms
Yulan Xiong, an assistant professor of neuroscience at UConn Health, and her research team have made a significant breakthrough in the treatment of Parkinson’s disease.… Read More »New discovery could lead to treatment for Parkinson’s disease
Rhomboid proteases have emerged as promising targets for novel drug development. Recently, a team of researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) made a… Read More »New mechanism for regulating rhomboid protease activity discovered
Researchers from Keio University School of Medicine in Tokyo have conducted an early clinical trial demonstrating the potential of the Parkinson’s disease drug ropinirole in… Read More »Parkinson’s drug ropinirole shows promise in slowing ALS progression, reveals early clinical trial
A recent study conducted by Professor Per Saris and his team at the University of Helsinki has shed light on the potential cause of Parkinson’s… Read More »Study links desulfovibrio bacteria to Parkinson’s disease and aggregation of α-synuclein protein